Adjuvant chemotherapy for rectal cancer with complete pathological response (pCR) may not be necessary: a pooled analysis of 5491 patients

BACKGROUND: It is recommended postoperative adjuvant chemotherapy for all rectal cancers undergoing neo-chemoradiotherapy regardless of the final yield pathology. However, the role of adjuvant chemotherapy in pathological complete response (pCR) remains controversial. We aimed to identify the necess...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiang, Li, Ya-Qi, Ma, Xiao-ji, Zhang, Long, Cai, San-Jun, Peng, Jun-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515679/
https://www.ncbi.nlm.nih.gov/pubmed/31114447
http://dx.doi.org/10.1186/s12935-019-0851-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515679/
https://www.ncbi.nlm.nih.gov/pubmed/31114447
http://dx.doi.org/10.1186/s12935-019-0851-9

Ejemplares similares